Insights / Drug Pipeline

Specialty Pharmacy Pipeline: Drugs to Watch Report

Alzheimer’s, oncology and atopic dermatitis therapies in the approvals pipeline

BRIEFING
April 26, 2021
From the Editors
Specialty Report PDF cover image, click to download

Specialty Pharmacy Pipeline:
Drugs to Watch Report

Anticipated Launches | Q2 – Q3 2021

Download >

The Specialty Pharmacy Pipeline Drugs to Watch report for Q2 2021 to Q3 2021 highlights two drugs for the treatment of atopic dermatitis and several other medications with near-term approvals for conditions such as Alzheimer’s disease, oncology and psoriasis.

The report details anticipated impact on spend for these therapies, including potential shifts between pharmacy and medical, as well as planned updates to CVS Health’s Specialty Guideline Management.

Have questions about our approach to specialty utilization management? Ask Us
BRIEFING
April 26, 2021
From the Editors